Clinical Trials | Tempus Labs, Inc. / “TEMPUS GEMINI NSCLC SURVEILLANCE STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Non-Small Cell Lung Cancer (NSCLC

The University of Virginia is participating in a clinical trial research study for the adult ages 18 and over, who has a likely diagnosis of Non-Small Cell Lung Cancer (NSCLC) and will be undergoing a resection and / or biopsy of your tumor, and also might be starting medication to treat your cancer. The purpose of the study is to evaluate a new test being developed by Tempus for patients with Non-Small Cell Lung Cancer (NSCLC). The goal of this new test is to predict the likelihood of a patient's cancer coming back after treatment, and to further explore changes in patient’s tumors throughout treatment to see how they respond. Having a test like this could help doctors see whether a patient's cancer is coming back just by using a blood sample, instead of having to perform a more invasive tissue biopsy. Your participation in this study will last as long as the full study timeline for participants or until you withdraw. The anticipated time on the study will last up to approximately three years, though it may be extended by the Sponsor. Study-related procedure that are being done beyond your standard of care will be provided at no cost to you. Additional information can be found here: https://clinicaltrials.gov/study/NCT05236114